Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4931390 | 0.73 | — | — | |
| SCHEMBL4931403 | 0.68 | KDM4E (0.37) | KDM4EL3MBTL1KMT2AALDH1A1LMNA | |
| SCHEMBL4930377 | 0.65 | HTR1B (0.32) | KDM4EKMT2AHTTALDH1A1 | |
| SCHEMBL10361949 | 0.64 | MAPT (0.45) | KDM4EL3MBTL1KMT2AMAPTATM | |
| SCHEMBL22288178 | 0.63 | MAPT (0.41) | KDM4EL3MBTL1KMT2ALMNAMAPT | |
| SCHEMBL8211957 | 0.62 | TACR3 (0.42) | KDM4EL3MBTL1KMT2AALDH1A1GLA | |
| SCHEMBL8207670 | 0.62 | MAPT (0.43) | KDM4EL3MBTL1KMT2AMAPTATM | |
| SCHEMBL27462355 | 0.62 | ALDH1A1 (0.41) | KDM4EL3MBTL1KMT2AALDH1A1GLA | |
| SCHEMBL2113229 | 0.62 | MAPT (0.43) | KDM4EL3MBTL1KMT2AALDH1A1LMNA | |
| SCHEMBL11236029 | 0.62 | CYP1A2 (0.36) | KDM4EL3MBTL1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080299674-A1 | Novel Isonitrile Compound, Its Method Of Manufacture, A Marine Fouling Organism Larva Fluorescent, And A Method Of Detecting This Marine Fouling Organism Larva Using Said Marker | CENTRAL RESEARCH INSTITUTE OF ELECTRIC POWER INDUSTRY (JP) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299674-A1 | Novel Isonitrile Compound, Its Method Of Manufacture, A Marine Fouling Organism Larva Fluorescent, And A Method Of Detecting This Marine Fouling Organism Larva Using Said Marker | PFAS, FUCA1, FLNB | KDM4E 4252/4885L3MBTL1 530/4885KMT2A 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.